Bacterial effector subversion of host protein trafficking

细菌效应子颠覆宿主蛋白质运输

基本信息

项目摘要

DESCRIPTION (provided by applicant): Diarrheal disease caused by enteric bacteria has been universally established as an important endemic health threat and a major source of food borne disease. Over 76 million cases and 5,000 deaths result from food borne illness in the Unites States annually. Enterohemorrhagic E. coli (EHEC) is especially important because it is the leading cause of pediatric renal failure and is commonly transmitted via contaminated meat and vegetable products. In spite of the appreciated magnitude of the threat to human health caused by EHEC, we still do not fully understand how EHEC causes diarrhea by disrupting the normal cellular functions of the host intestine. The central hypothesis for the proposed research is that NleF contributes to EHEC virulence by subverting the function of the host Tmp21 (p23) protein, an important component of intracellular protein transport vesicles. The specific aims of this project are to 1) map the NleF/Tmp21 binding interface and 2) characterize the influence of NleF on host protein trafficking. This project will be significant because it will characterize how the EHEC virulence factor NleF interacts with the host protein transport machinery. These studies are expected to have a significant positive impact on the design of new strategies to combat diarrheal pathogens. PUBLIC HEALTH RELEVANCE: E. coli is a significant source of food borne disease caused by ingestion of under-cooked beef products or contaminated vegetables. An E. coli protein has been discovered that may contribute to diarrheal disease by altering the function of mammalian intracellular protein transport machinery. The applicant is characterizing the biological activity of this protein with the goal of developing new therapeutic strategies for E. coli and related diarrheal pathogens.
描述(申请人提供):由肠道细菌引起的腹泻病已被普遍认为是一种重要的地方性健康威胁和食源性疾病的主要来源。在美国,每年有超过7600万病例和5000人死于食源性疾病。肠出血性大肠杆菌(EHEC)尤其重要,因为它是儿童肾衰竭的主要原因,通常通过受污染的肉类和蔬菜产品传播。尽管肠出血性大肠杆菌对人类健康的威胁程度已得到充分认识,但我们仍然不完全了解肠出血性大肠杆菌是如何通过破坏宿主肠道的正常细胞功能而导致腹泻的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Philip Ross Hardwidge其他文献

Philip Ross Hardwidge的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Philip Ross Hardwidge', 18)}}的其他基金

T3SS Effector Regulation of Bacterial Metabolism
T3SS 细菌代谢的效应器调节
  • 批准号:
    10425770
  • 财政年份:
    2022
  • 资助金额:
    $ 7.5万
  • 项目类别:
Molecular and Cellular Biology Core
分子和细胞生物学核心
  • 批准号:
    10642676
  • 财政年份:
    2020
  • 资助金额:
    $ 7.5万
  • 项目类别:
Molecular and Cellular Biology Core
分子和细胞生物学核心
  • 批准号:
    10397674
  • 财政年份:
    2020
  • 资助金额:
    $ 7.5万
  • 项目类别:
Functions of Translocated Bacterial Glycosyltransferases
易位细菌糖基转移酶的功能
  • 批准号:
    9222103
  • 财政年份:
    2016
  • 资助金额:
    $ 7.5万
  • 项目类别:
An enterotoxigenic E. coli protein that antagonizes the NF-kappaB pathway
一种拮抗 NF-kappaB 通路的产肠毒素大肠杆菌蛋白
  • 批准号:
    8891351
  • 财政年份:
    2014
  • 资助金额:
    $ 7.5万
  • 项目类别:
Bacterial effectors targeting the IKK/NF-kB pathway
针对 IKK/NF-kB 通路的细菌效应子
  • 批准号:
    8791592
  • 财政年份:
    2013
  • 资助金额:
    $ 7.5万
  • 项目类别:
Bacterial effectors targeting the IKK/NF-kB pathway
针对 IKK/NF-kB 通路的细菌效应子
  • 批准号:
    9188797
  • 财政年份:
    2013
  • 资助金额:
    $ 7.5万
  • 项目类别:
Bacterial effectors targeting the IKK/NF-kB pathway
针对 IKK/NF-kB 通路的细菌效应子
  • 批准号:
    8495491
  • 财政年份:
    2013
  • 资助金额:
    $ 7.5万
  • 项目类别:
Reverse vaccinology of enterotoxigenic E. coli
产肠毒素大肠杆菌的反向疫苗学
  • 批准号:
    8518225
  • 财政年份:
    2012
  • 资助金额:
    $ 7.5万
  • 项目类别:
Bacterial effectors targeting the IKK/NF-kB pathway
针对 IKK/NF-kB 通路的细菌效应子
  • 批准号:
    8589734
  • 财政年份:
    2012
  • 资助金额:
    $ 7.5万
  • 项目类别:

相似海外基金

New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
  • 批准号:
    10649771
  • 财政年份:
    2023
  • 资助金额:
    $ 7.5万
  • 项目类别:
Derivation and validation of a clinical prediction rule to identify febrile infants 61 to 90 days old at low and non-negligible risk of invasive bacterial infections
推导和验证临床预测规则,以识别 61 至 90 天大的发热婴儿,其侵袭性细菌感染的风险较低且不可忽略
  • 批准号:
    10574286
  • 财政年份:
    2023
  • 资助金额:
    $ 7.5万
  • 项目类别:
Structural and functional studies of YbtPQ for fighting bacterial infections
YbtPQ 对抗细菌感染的结构和功能研究
  • 批准号:
    10644889
  • 财政年份:
    2023
  • 资助金额:
    $ 7.5万
  • 项目类别:
A gut feeling: How can gastrointestinal bacterial infections alter female reproductive tract immunity and control of sexually transmitted infections
直觉:胃肠道细菌感染如何改变女性生殖道免疫力和性传播感染的控制
  • 批准号:
    MR/X031993/1
  • 财政年份:
    2023
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Research Grant
Molecular probes to diagnose pathoadapatations in bacterial infections
诊断细菌感染病理适应的分子探针
  • 批准号:
    EP/X014479/1
  • 财政年份:
    2023
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Research Grant
Using Small Area Variation Analysis to Investigate Sources of Practice Variation for Febrile Infants at Risk for Invasive Bacterial Infections
使用小面积变异分析来调查有侵袭性细菌感染风险的发热婴儿的实践变异来源
  • 批准号:
    10588846
  • 财政年份:
    2023
  • 资助金额:
    $ 7.5万
  • 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
  • 批准号:
    10674221
  • 财政年份:
    2023
  • 资助金额:
    $ 7.5万
  • 项目类别:
SimCell vaccines against Staphylococcus aureus bacterial infections
针对金黄色葡萄球菌细菌感染的 SimCell 疫苗
  • 批准号:
    10073241
  • 财政年份:
    2023
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Grant for R&D
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
  • 批准号:
    2306943
  • 财政年份:
    2023
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Standard Grant
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 7.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了